Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
14 of 16 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
250-500mg yeast beta-glucan OR 3g oat beta-glucan for cholesterol
Morning, With or without food
Yeast-derived 1,3/1,6 beta-glucan (Wellmune is most studied)
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
4-12 weeks
During illness
4-8 weeks
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Galactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis
The American journal of clinical nutrition (2023) · Meta analysis · n=2685
Galactomannans had the highest effect on reducing the levels of HbA1c (SUCRA: 92.33%) and fasting blood glucose (SUCRA: 85.92%).
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=927
The results were presented with the weighted mean difference (WMD) with a 95% CI.
A systematic review and meta-analysis of beta-glucan consumption on glycemic control in hypercholesterolemic individuals
International journal of food sciences and nutrition (2015) · Meta analysis · n=603
Summary estimates of weighted mean differences (WMD) and 95% confidence interval was 0.05 mmol/L (-0.11, 0.02) for fasting glucose concentration and 0.75 pmol/L (-1.82, 3.32) for fasting insulin concentrations.
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Based on multiple meta-analyses showing 0.24-0.32 mmol/L LDL reduction. Effect specific to oat beta-glucan, not yeast forms. FDA-approved health claim at 3g dose. GI side effects more common with oat forms.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 7/10) and wins in 2 of 3 categories.
For reduce inflammation, Omega-3 has a higher relevance score (90 vs 70).
No known interactions between Beta-Glucans and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.